Literature DB >> 21291271

An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform.

Shan Gao1, Melissa J Simon, Christopher D Hue, Barclay Morrison, Scott Banta.   

Abstract

Cell penetrating peptides (CPPs) have tremendous potential for use in gene and drug delivery applications. The selection of new CPPs with desired capabilities from randomized peptide libraries is challenging, since the CPP phenotype is a compn>lex selection target. Here we report the discovery of an unusual new CPP from a randomized peptide library using a functional selection system based on plasmid dispn>lay (n>an class="Disease">PD). After four rounds of screening of a 14-mer peptide library over PC12 cells, several peptides were identified and tested for their ability to deliver the green fluorescent protein (GFP). One peptide (SG3) exhibited a cell penetrating phenotype; however, unlike other well-known CPPs such as TAT or Penetratin, the newly identified peptide was not highly cationic. The PD protocol necessitated the addition of a cationic lipid (Lipofectamine2000), and in the presence of this compound, the SG3 peptide significantly outperformed the well-known TAT CPP in the delivery of GFP to PC12 cells and primary astrocytes. When the SG3 peptide was fused to the pro-apoptotic BH3 peptide from the Bak protein, significant cell death was induced in cultured primary astrocytes, indicating relevant, intracellular delivery of a functional cargo. The PD platform is a useful method for identifying functional new CPPs from randomized libraries with unique delivery capabilities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21291271      PMCID: PMC3098927          DOI: 10.1021/cb100423u

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  51 in total

1.  Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes.

Authors:  Henry D Herce; Angel E Garcia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

2.  The amino-terminal peptide of Bax perturbs intracellular Ca2+ homeostasis to enhance apoptosis in prostate cancer cells.

Authors:  Na Li; Peihui Lin; Chuanxi Cai; Zui Pan; Noah Weisleder; Jianjie Ma
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-17       Impact factor: 4.249

Review 3.  Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.

Authors:  Tamaki Endoh; Takashi Ohtsuki
Journal:  Adv Drug Deliv Rev       Date:  2009-04-19       Impact factor: 15.470

4.  A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.

Authors:  Laurence Crombez; Gudrun Aldrian-Herrada; Karidia Konate; Quan N Nguyen; Gary K McMaster; Robert Brasseur; Frederic Heitz; Gilles Divita
Journal:  Mol Ther       Date:  2008-10-28       Impact factor: 11.454

5.  Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.

Authors:  Antonella Bugatti; Chiara Urbinati; Cosetta Ravelli; Erik De Clercq; Sandra Liekens; Marco Rusnati
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

6.  Identification and characterization of a novel cell-penetrating peptide.

Authors:  Jingwei Sheng; George Oyler; Bin Zhou; Kim Janda; Charles B Shoemaker
Journal:  Biochem Biophys Res Commun       Date:  2008-12-11       Impact factor: 3.575

7.  Bifunctional chimeric fusion proteins engineered for DNA delivery: optimization of the protein to DNA ratio.

Authors:  Shan Gao; Melissa J Simon; Barclay Morrison; Scott Banta
Journal:  Biochim Biophys Acta       Date:  2009-03

Review 8.  Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells.

Authors:  G M K Poon; J Gariépy
Journal:  Biochem Soc Trans       Date:  2007-08       Impact factor: 5.407

Review 9.  Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.

Authors:  Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

10.  A novel use of TAT-EGFP to validate techniques to alter osteosarcoma cell surface glycosaminoglycan expression.

Authors:  Arjuna Kumarasuriyar; Christian Dombrowski; David A Rider; Victor Nurcombe; Simon M Cool
Journal:  J Mol Histol       Date:  2007-09-21       Impact factor: 3.156

View more
  5 in total

1.  Direct protein delivery to mammalian cells using cell-permeable Cys2-His2 zinc-finger domains.

Authors:  Thomas Gaj; Jia Liu
Journal:  J Vis Exp       Date:  2015-03-25       Impact factor: 1.355

2.  Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications.

Authors:  Zhengrong Guo; Huanyan Peng; Jiwen Kang; Dianxing Sun
Journal:  Biomed Rep       Date:  2016-03-23

Review 3.  Modifications of natural peptides for nanoparticle and drug design.

Authors:  Andrew P Jallouk; Rohun U Palekar; Hua Pan; Paul H Schlesinger; Samuel A Wickline
Journal:  Adv Protein Chem Struct Biol       Date:  2015-03-12       Impact factor: 3.507

4.  Protein delivery using Cys2-His2 zinc-finger domains.

Authors:  Thomas Gaj; Jia Liu; Kimberly E Anderson; Shannon J Sirk; Carlos F Barbas
Journal:  ACS Chem Biol       Date:  2014-06-19       Impact factor: 5.100

5.  Cyclic Peptoid-Peptide Hybrids as Versatile Molecular Transporters.

Authors:  Claudine Nicole Herlan; Anna Meschkov; Ute Schepers; Stefan Bräse
Journal:  Front Chem       Date:  2021-06-25       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.